TBL1XR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.129000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.406180E-01
Normal-vs-Stage2
4.925800E-01
Normal-vs-Stage3
1.251440E-01
Normal-vs-Stage4
8.097600E-01
Stage1-vs-Stage2
1.986440E-01
Stage1-vs-Stage3
6.748800E-01
Stage1-vs-Stage4
1.317820E-01
Stage2-vs-Stage3
1.312180E-01
Stage2-vs-Stage4
2.176400E-01
Stage3-vs-Stage4
1.435040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.010400E-01
Normal-vs-AfricanAmerican
6.459000E-01
Normal-vs-Asian
4.627600E-01
Caucasian-vs-AfricanAmerican
7.626800E-01
Caucasian-vs-Asian
9.809200E-01
AfricanAmerican-vs-Asian
8.119600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.929600E-01
Normal-vs-Female
4.604800E-01
Male-vs-Female
6.477000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.899000E-01
Normal-vs-Age(41-60Yrs)
6.484000E-01
Normal-vs-Age(61-80Yrs)
3.643000E-01
Normal-vs-Age(81-100Yrs)
2.013200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.559000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.426200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.940200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.190200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.233000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.242400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.144200E-01
Normal-vs-Daily Drinker
3.103000E-01
Normal-vs-Weekly Drinker
1.637560E-01
Normal-vs-Occasional Drinker
9.059000E-01
Normal-vs-Social Drinker
3.227200E-01
Non Drinker-vs-Daily Drinker
9.257200E-01
Non Drinker-vs-Weekly Drinker
7.375400E-01
Non Drinker-vs-Occasional Drinker
9.078800E-03
Non Drinker-vs-Social Drinker
4.127200E-01
Daily Drinker-vs-Weekly Drinker
8.445000E-01
Daily Drinker-vs-Occasional Drinker
2.642500E-02
Daily Drinker-vs-Social Drinker
4.604600E-01
Weekly Drinker-vs-Occasional Drinker
1.383980E-02
Weekly Drinker-vs-Social Drinker
2.835200E-01
Occasional Drinker-vs-Social Drinker
8.490000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.168800E-01
Normal-vs-Grade 2
9.117700E-03
Normal-vs-Grade 3
1.149610E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.815600E-04
Grade 1-vs-Grade 3
2.403700E-03
Grade 1-vs-Grade 4
2.168800E-01
Grade 2-vs-Grade 3
9.116400E-01
Grade 2-vs-Grade 4
9.117700E-03
Grade 3-vs-Grade 4
1.149610E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.891000E-01
Normal-vs-NonDiabetic
3.968600E-01
Diabetic-vs-NonDiabetic
4.059600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.220800E-01
Normal-vs-NoPancreatitis
3.530200E-01
Pancreatitis-vs-NoPancreatitis
4.397200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.178600E-01
Normal-vs-N1
4.872400E-01
N0-vs-N1
3.214400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.211000E-01
Normal-vs-TP53-NonMutant
3.112800E-01
TP53-Mutant-vs-TP53-NonMutant
4.31440000003835E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
